Cooper; Kevin D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cooper; Kevin D..The latest application filed is for "vitamin d as an immune modulator to prevent immune-related complication from covid-19 infection".

Company Profile

1.12.17

Cooper; Kevin D. - Moreland Hills OH
Cooper; Kevin D. - Cleveland OH
COOPER; KEVIN D. - MOELAND HILLS OH
Cooper; Kevin D. - Ann Arbor MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Vitamin D As An Immune Modulator To Prevent Immune-related Complication From Covid-19 Infection App 20210369741 - Lu; Kurt Q. ; et al.	2021-12-02
Biomarkers for human monocyte myeloid-derived suppresor cells Grant 10,288,619 - Cooper , et al.	2019-05-14
Methods of detecting cancer Grant 10,066,020 - Soler , et al. September 4, 2	2018-09-04
Methods Of Detecting Cancer App 20180030145 - Soler; David C. ; et al.	2018-02-01
Biomarkers For Human Monocyte Myeloid0derived Suppresor Cells App 20170192006 - Cooper; Kevin D. ; et al.	2017-07-06
Methods of generating hyper INOS expressing cells and uses thereof Grant 9,421,197 - Lu , et al. August 23, 2	2016-08-23
Photodynamic therapy including light pretreatment Grant 9,033,962 - Cooper , et al. May 19, 2	2015-05-19
Methods Of Generating Hyper Inos Expressing Cells And Uses Thereof App 20140335105 - LU; KURT Q. ; et al.	2014-11-13
Methods and reagents for identifying/isolating T regulatory (Treg) cells and for treating individuals Grant 8,815,526 - Garaczi , et al. August 26, 2	2014-08-26
Methods of generating hyper iNOS expressing cells and uses thereof Grant 8,790,925 - Lu , et al. July 29, 2	2014-07-29
Methods Of Generating Hyper Inos Expressing Cells And Uses Thereof App 20140170165 - Lu; Kurt Q. ; et al.	2014-06-19
Photodynamic Therapy System, Device And Associated Method Of Treatment App 20130304019 - Cooper; Kevin D. ; et al.	2013-11-14
Phthalocyanine-based Antifungal Agents App 20120265121 - Baron; Elma D. ; et al.	2012-10-18
Topical delivery of phthalocyanines Grant 8,211,883 - Cooper , et al. July 3, 2	2012-07-03
Photodynamic Therapy Including Light Pretreatment App 20120071810 - Cooper; Kevin D. ; et al.	2012-03-22
Topical Delivery Of Phthalocyanines App 20090156552 - Cooper; Kevin D. ; et al.	2009-06-18
Methods and Reagents for Identifying/Isolating T Regulatory (Treg) Cells and for Treating Individuals App 20080279834 - Garaczi; Edina ; et al.	2008-11-13
Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction Grant 7,323,171 - Wallner , et al. January 29, 2	2008-01-29
Methods for treating or preventing skin disorders using CD2-binding agents App 20070031443 - Vaishnaw; Akshay K. ; et al.	2007-02-08
Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction App 20060084107 - Wallner; Barbara P. ; et al.	2006-04-20
Methods for treating or preventing skin disorders using cd2-binding agents App 20040170635 - Vaishnaw, Akshay K. ; et al.	2004-09-02
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction Grant 6,764,681 - Wallner , et al. July 20, 2	2004-07-20
Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction App 20040136987 - Wallner, Barbara P. ; et al.	2004-07-15
Methods for treating or preventing skin disorders using CD2-binding agents App 20030185824 - Vaishnaw, Akshay K. ; et al.	2003-10-02
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction App 20020009449 - Wallner, Barbara P. ; et al.	2002-01-24
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction Grant 6,162,432 - Wallner , et al. December 19, 2	2000-12-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.